Interleukin-6 is an autocrine growth factor in human prostate cancer

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2159-2165

  Giri, D ^a   Ozen, M ^a   Ittmann, M ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STAT3 PROTEIN;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER MORTALITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN PHOSPHORYLATION;

EID: 0035180451     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63067-2     Document Type: Article

References (24)

1. Role of interleukin-6 in the pathogenesis of multiple myeloma
2. A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma
3. Autocrine growth promotion by multiple hematopoietic growth factors in the established renal cell carcinoma line KU-19-20
4. Effect of interleukin-6 on the growth of human lung cancer cell line
5. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia
6. Characterization of the role of IL-6 in the progression of prostate cancer
7. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro
8. Interleukin-6: A candidate mediator of human prostate cancer morbidity
9. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells
10. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway
11. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
12. Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells
13. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue
14. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate
15. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells
16. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation
17. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma
18. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
19. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells
20. Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines
21. Cytokine variations in patients with hormone treated prostate cancer
22. Serum interleukin 6 as a prognostic factor in patients with prostate cancer
23. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site
24. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA